{
  "pmcid": "11463927",
  "sha256": "964c4094094a27d4c71c80325e2a4978a0c5e8c108c049157dd1bca194d465cd",
  "timestamp_utc": "2025-11-09T22:03:58.212502+00:00",
  "model_used": "gpt-4o",
  "readability": {
    "flesch_kincaid": 12.879406698564594,
    "reading_ease": 27.540513556618833,
    "word_count": 209
  },
  "consort_scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 1,
        "evidence": "Randomised Controlled Trial of Caudal Adjuvants in Pediatric Surgery"
      },
      "Trial_Design": {
        "score": 1,
        "evidence": "63 children aged 1–6 years with ASA physical status I or II were randomised"
      },
      "Participants": {
        "score": 2,
        "evidence": "63 children aged 1–6 years with ASA physical status I or II were randomised to receive a caudal block"
      },
      "Intervention": {
        "score": 2,
        "evidence": "randomised to receive a caudal block with either dexmedetomidine 1 μg/kg (Group D), morphine 30 μg/kg (Group M), or clonidine 1.5 μg/kg (Group C), along with 0.2% ropivacaine"
      },
      "Objective": {
        "score": 1,
        "evidence": "This randomised controlled trial aimed to compare the duration of postoperative analgesia provided by morphine, clonidine, and dexmedetomidine"
      },
      "Method_Outcome": {
        "score": 2,
        "evidence": "The primary outcome was the duration of analgesia, measured until the first rescue analgesic was required"
      },
      "Randomisation_Allocation": {
        "score": 2,
        "evidence": "Randomisation was computer-generated with allocation concealment using sealed envelopes"
      },
      "Blinding": {
        "score": 3,
        "evidence": "Blinding included patients, clinicians, and outcome assessors"
      },
      "Number_Randomised": {
        "score": 1,
        "evidence": "63 children aged 1–6 years with ASA physical status I or II were randomised"
      },
      "Number_Analysed": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Result_Outcome": {
        "score": 2,
        "evidence": "The median duration of analgesia was 380 minutes for Group D, 360 minutes for Group C, and 405 minutes for Group M, with no statistically significant difference (P = 0.843)"
      },
      "Harms": {
        "score": 1,
        "evidence": "Adverse events included intraoperative hypotension in 43.5% of Group D, 27.8% of Group C, and 22.7% of Group M (P = 0.299)"
      },
      "Trial_Registration": {
        "score": 1,
        "evidence": "Trial registration: CTRI/2020/07/026481"
      },
      "Funding": {
        "score": 0,
        "evidence": "Funding: None"
      }
    },
    "total_score": 19,
    "max_score": 25
  }
}